日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Confirmation of Fixed Quarterly Riliprubart Regimen in Patients with Cold Agglutinin Disease Using Population PK/PD and Exposure-Response Analyses

利用群体药代动力学/药效学和暴露-反应分析确认利普鲁巴特固定季度给药方案在冷凝集素病患者中的疗效

期刊:Clinical Pharmacology & Therapeutics
影响因子:5.5
doi:10.1002/cpt.3692
Chow, Timothy; Wardecki, Marek; Storek, Michael; Wong, Nancy
发表日期：2025
文献求助 收藏

Diagnostic pitfalls: soft-tissue sarcomas initially misdiagnosed as benign vascular anomalies-a case report and systematic review

诊断陷阱：软组织肉瘤最初被误诊为良性血管畸形——病例报告和系统综述

期刊:Oncology Reviews
影响因子:5.2
doi:10.3389/or.2025.1681090
Styczewska, Malgorzata; Lyzinska, Weronika; Wardecki, Stanislaw Maria; Zajaczkowska, Joanna; Kunc, Michal; Mikaszewski, Boguslaw; Maciag, Rafal; Regent, Bartosz; Wyrzykowski, Dariusz; Jankowska, Anna; Swieton, Dominik; Sinacka, Katarzyna; Zak-Jasinska, Katarzyna; Jedrzejczyk, Anna; Krawczyk, Malgorzata A; Bien, Ewa
发表日期：2025
文献求助 收藏

Operando anomalous X-ray powder diffraction interleaved with X-ray absorption spectroscopy using a scanning 2D imaging detector on the XMaS beamline: design, implementation and performance

利用XMaS光束线上的扫描二维成像探测器，将原位异常X射线粉末衍射与X射线吸收光谱交错进行：设计、实现和性能

期刊:
影响因子:
doi:10.1107/S1600576725007022
Wardecki, Dariusz; Thompson, Paul B J; Mlekodaj, Kinga; Dowsett, Mark G; Adriaens, Mieke; Knorpp, Amy J; Dejoie, Catherine; Góra-Marek, Kinga; van Bokhoven, Jeroen A; Newton, Mark A; Rzepka, Przemyslaw
发表日期：2025
文献求助 收藏

Quantifying the Hydration-Dependent Dynamics of Cu Migration and Activity in Zeolite Omega for the Partial Oxidation of Methane

量化沸石Ω中铜迁移和活性的水合依赖性动力学及其对甲烷部分氧化的影响

期刊:Angewandte Chemie-International Edition
影响因子:16.9
doi:10.1002/anie.202407395
Wieser, Johannes; Wardecki, Dariusz; Fischer, Jörg W A; Newton, Mark A; Dejoie, Catherine; Knorpp, Amy J; Hansen, Thomas C; Jeschke, Gunnar; Rzepka, Przemyslaw; van Bokhoven, Jeroen A
发表日期：2024
文献求助 收藏

Assessment of Lipophilicity Parameters of Antimicrobial and Immunosuppressive Compounds

抗菌和免疫抑制剂亲脂性参数的评估

期刊:Molecules
影响因子:4.6
doi:10.3390/molecules28062820
Wardecki, Dawid; Dołowy, Małgorzata; Bober-Majnusz, Katarzyna
免疫/内分泌
发表日期：2023
文献求助 收藏

Efficacy and Safety of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart in People with Diabetes Treated for 26 Weeks with Multiple Daily Injections in Combination with Insulin Glargine: A Randomized Open-Label Trial (GEMELLI 1)

胰岛素门冬生物类似药 SAR341402 与原研胰岛素门冬在接受每日多次注射联合胰岛素甘精治疗 26 周的糖尿病患者中的疗效和安全性：一项随机开放标签试验 (GEMELLI 1)

期刊:Diabetes Technology & Therapeutics
影响因子:6.3
doi:10.1089/dia.2019.0382
Garg, Satish K; Wernicke-Panten, Karin; Wardecki, Marek; Kramer, Daniel; Delalande, Francois; Franek, Edward; Sadeharju, Karita; Monchamp, Travis; Mukherjee, Bhaswati; Shah, Viral N
代谢
糖尿病
免疫/内分泌
发表日期：2020
文献求助 收藏

Safety, Immunogenicity, and Glycemic Control of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart in People with Diabetes Also Using Insulin Glargine: 12-Month Results from the GEMELLI 1 Trial

在同时使用甘精胰岛素的糖尿病患者中，胰岛素门冬生物类似药SAR341402与原研胰岛素门冬相比的安全性、免疫原性和血糖控制：GEMELLI 1试验的12个月结果

期刊:Diabetes Technology & Therapeutics
影响因子:6.3
doi:10.1089/dia.2020.0008
Garg, Satish K; Wernicke-Panten, Karin; Wardecki, Marek; Kramer, Daniel; Delalande, Francois; Franek, Edward; Sadeharju, Karita; Monchamp, Travis; Miossec, Patrick; Mukherjee, Bhaswati; Shah, Viral N
代谢
糖尿病
免疫/内分泌
发表日期：2020
文献求助 收藏

Efficacy and Safety of Flexible Versus Fixed Dosing Intervals of Insulin Glargine 300 U/mL in People with Type 2 Diabetes

胰岛素甘精300 U/mL灵活给药间隔与固定给药间隔治疗2型糖尿病患者的疗效和安全性比较

期刊:Diabetes Technology & Therapeutics
影响因子:6.3
doi:10.1089/dia.2015.0290
Riddle, Matthew C; Bolli, Geremia B; Home, Philip D; Bergenstal, Richard M; Ziemen, Monika; Muehlen-Bartmer, Isabel; Wardecki, Marek; Vinet, Laetitia; Jeandidier, Nathalie; Yki-Järvinen, Hannele
代谢
糖尿病
免疫/内分泌
发表日期：2016
文献求助 收藏

Glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: the EDITION 2 randomized 12-month trial including 6-month extension

在接受基础胰岛素和口服降糖药治疗的 2 型糖尿病患者中，比较新型甘精胰岛素 300 U/ml 与甘精胰岛素 100 U/ml 的血糖控制和低血糖发生率：EDITION 2 随机 12 个月试验（含 6 个月扩展期）。

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.12532
Yki-Järvinen, H; Bergenstal, R M; Bolli, G B; Ziemen, M; Wardecki, M; Muehlen-Bartmer, I; Maroccia, M; Riddle, M C
代谢
糖尿病
免疫/内分泌
发表日期：2015
文献求助 收藏

From a traditional medicinal plant to a rational drug: understanding the clinically proven wound healing efficacy of birch bark extract

从传统药用植物到合理药物：了解桦树皮提取物经临床验证的伤口愈合功效

期刊:PLoS One
影响因子:2.9
doi:10.1371/journal.pone.0086147
Sandra Ebeling, Katrin Naumann, Simone Pollok, Tina Wardecki, Sabine Vidal-Y-Sy, Juliana M Nascimento, Melanie Boerries, Gudula Schmidt, Johanna M Brandner, Irmgard Merfort
信号转导
发表日期：2014
文献求助 收藏